Welcome to our dedicated page for Embecta SEC filings (Ticker: EMBC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Embecta Corp. (EMBC) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations as a global diabetes care and medical supplies company. As an issuer listed on The Nasdaq Global Select Market, embecta’s SEC filings cover topics such as financial performance, governance, compensation, and material corporate events.
On this page, you can review current reports on Form 8-K, where embecta discloses items like quarterly and full-year financial results, dividend declarations, and changes to its board of directors. For example, the company has used Form 8-K to report earnings for specific quarters and fiscal years, and to describe director departures and planned leadership changes on the board.
Embecta also files a definitive proxy statement on Schedule 14A, which outlines proposals for its annual meeting of stockholders, including the election of directors, ratification of the independent registered public accounting firm, advisory votes on executive compensation, and amendments to equity-based compensation plans. The proxy statement provides information on board composition, committee structures, director skills and experience, and governance practices.
In addition to these filings, investors can access embecta’s annual and quarterly reports referenced in its proxy materials, which contain audited financial statements, segment and product family revenue breakdowns, and discussions of strategic priorities such as strengthening the core business, expanding the product portfolio, and increasing financial flexibility.
Stock Titan’s platform enhances these regulatory disclosures with AI-powered summaries that highlight key points from lengthy documents, helping readers understand the implications of embecta’s 8-Ks, proxy statements, and other filings. Real-time updates from EDGAR, combined with structured access to forms related to governance and financial reporting, allow users to follow how embecta’s strategy, board decisions, and financial performance are reflected in its official SEC record.
Embecta Corp. furnished a press release announcing results for the quarter ended June 30, 2025. The company submitted an 8-K to share this update and included the full press release as Exhibit 99.1. The filing notes the update relates to results of operations and financial condition. Shares trade on Nasdaq under EMBC.